Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone propionate nasal spray 50 mcg/actuation

fluticasone propionate nasal spray · Teva Pharmaceuticals USA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone propionate nasal spray 50 mcg/actuation, covering 2023-06-08 to 2023-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients [Phase 3]

See pricing